Efficacy and safety offerric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease:a Meta-analysis
Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease(CKD),and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials(RCTs) relating to treatment of hyperphosphate...
Saved in:
| Main Authors: | WANG Shan-shan, WEN Tong, ZHANG Xin-zhou |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2020-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57905104&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ferric citrate for patients with chronic kidney disease:a Meta-analysis
by: Wan Hong-pin, et al.
Published: (2021-01-01) -
Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01) -
Meta analysis of efficiency and safety of sevelamer in the treatment of hyperphosphatemia in patients with maintenance hemodialysis
by: YANG Ling
Published: (2018-01-01) -
Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease
by: Wang Yu-han, et al.
Published: (2025-02-01) -
Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease
by: Wang Yu-han, et al.
Published: (2025-02-01)